Stochastic and proliferative events initiated from a single cell can disrupt homeostatic balance and lead to fatal disease processes such as cancer metastasis. To overcome metastasis, it is necessary to detect and quantify sparsely distributed metastatic cells throughout the body at early stages. Here, we demonstrate that clear, unobstructed brain/ body imaging cocktails and computational analysis (CUBIC)-based cancer (CUBIC-cancer) analysis with a refractive index (RI)-optimized protocol enables comprehensive cancer cell profiling of the whole body and organs. We applied CUBIC-cancer analysis to 13 mouse models using nine cancer cell lines and spatiotemporal quantification of metastatic cancer progression at single-cell resolution. CUBICcancer analysis suggests that the epithelial-mesenchymal transition promotes not only extravasation but also cell survival at metastatic sites. CUBICcancer analysis is also applicable to pharmacotherapeutic profiling of anti-tumor drugs. CUBIC-cancer analysis is compatible with in vivo bioluminescence imaging and 2D histology. We suggest that a scalable analytical pipeline with these three modalities may contribute to addressing currently incurable metastatic diseases.
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In Brief
Kubota et al. find that CUBIC-cancer analysis can profile cancer metastasis at a single-cell level in a whole-animal context. In addition, CUBIC-cancer analysis can bridge the resolution gap between in vivo bioluminescence imaging and histology. This analytical pipeline would contribute to the profiling of biological functions of whole organs.
SUMMARY
Stochastic and proliferative events initiated from a single cell can disrupt homeostatic balance and lead to fatal disease processes such as cancer metastasis. To overcome metastasis, it is necessary to detect and quantify sparsely distributed metastatic cells throughout the body at early stages. Here, we demonstrate that clear, unobstructed brain/ body imaging cocktails and computational analysis (CUBIC)-based cancer (CUBIC-cancer) analysis with a refractive index (RI)-optimized protocol enables comprehensive cancer cell profiling of the whole body and organs. We applied CUBIC-cancer analysis to 13 mouse models using nine cancer cell lines and spatiotemporal quantification of metastatic cancer progression at single-cell resolution. CUBICcancer analysis suggests that the epithelial-mesenchymal transition promotes not only extravasation but also cell survival at metastatic sites. CUBICcancer analysis is also applicable to pharmacotherapeutic profiling of anti-tumor drugs. CUBIC-cancer analysis is compatible with in vivo bioluminescence imaging and 2D histology. We suggest that a scalable analytical pipeline with these three modalities may contribute to addressing currently incurable metastatic diseases.
INTRODUCTION
Rudolf Virchow, the father of modern pathology, declared that the body is a ''cell state, in which every cell is a citizen'' and disease is ''merely a conflict of citizens in this state brought about by the action of external forces'' (Nicholls, 1927) . His cell theory brought the current concept of cellular pathology based on microscopic histological analysis to the early model of pathology, which largely relied on clinical symptoms and gross appearances in patients. Thereafter, comprehensive analysis and decoding of the more than 100 billion cells comprising the mammalian body have become one of the ultimate goals in biology and medicine. Although recent advances in a series of live-imaging systems have provided important breakthroughs to examine dynamics at the whole-body scale, it is still difficult to clarify the generation and progression of diseases with stochastic and proliferative processes, such as autoimmune and malignant neoplastic diseases (Saadatpour et al., 2017; Takahashi et al., 2015). In particular, tumor metastasis can be initiated by a few cancer cells, and use of current imaging systems is a challenge due to their limited spatial resolution. Additionally, according to metastasis images from these imaging systems, 3D reconstitution of possibly affected organs by 2D histology is labor intensive. To bridge the spatial resolution gap between these approaches, a fundamentally novel analytical platform is required. To detect and quantify sparsely distributed metastatic cells at early stages of cancer metastasis, it is necessary to detect metastatic cells throughout the whole body and visualize individual tumor microenvironments.
Tissue-clearing-based 3D imaging is a most promising strategy for the visualization of the entire mouse body/organs at single-cell resolution (Susaki and . Spalteholz (1914) first established the basic concept of human tissue clearing based on organic solvents. Although tissue-clearing protocols have been available for a century, it is still difficult to comprehensively visualize sparsely distributed pathogenic cells throughout the mouse body using current tissueclearing protocols.
In this study, we first investigate optimal refractive indices (RIs) ranging from 1.44 to 1.52 against each organ, and we demonstrate that an RI of 1.52 has the highest clearing efficiency among major organs. Then, we describe a highly efficient clearing (legend continued on next page) protocol for the whole adult mouse body using a more efficient delipidation cocktail, clear unobstructed brain/body imaging cocktails and computational analysis (CUBIC)-L, and an optimized RI-matching medium, CUBIC-R. The specimens treated with this clearing protocol are clear enough to use for 3D imaging of the entire mouse body. The combination of light-sheet fluorescent microscopy (LSFM) and confocal laser-scanning microscopy (CLSM) enables the detection of cancer micrometastases in various kinds of mouse models. Our CUBIC-cancer analysis is compatible with the in vivo bioluminescence imaging system and conventional 2D histology, successfully bridging the spatial resolution gap between these approaches. CUBIC-cancer analysis is applied here to 13 mouse models using nine cancer cell lines, and it distinguishes different hematogenous metastatic patterns, such as angiogenic growth and co-optive growth. Moreover, CUBIC-cancer analysis enables the spatiotemporal quantification of metastatic cells even in the early stages of metastasis formation. In addition, we investigated the in vivo role of transforming growth factor b (TGF-b) signaling in lung metastasis, and we applied an in vivo system to evaluate the therapeutic effect of anti-cancer drugs on cancer metastasis. CUBIC-cancer analysis provides a fundamental platform for the analysis of the metastatic growth and progression of cancer throughout the body.
RESULTS
Optimized RI Cocktail Enables Whole-Body and Whole-Organ Clearing in Adult Mice Previously, we achieved the whole-body imaging of postnatal day 1 mice at single-cell resolution by whole-body clearing based on a ScaleCUBIC-1 reagent (Tainaka et al., 2014). However, it remains difficult to sensitively and comprehensively detect the distribution of cancer cells that have metastasized to organs throughout the body of adult mice because of an insufficient delipidation efficiency and the unoptimized RI value of the ScaleCUBIC-1 reagent. To address these issues, we have performed comprehensive chemical profiling of hydrophilic chemicals to characterize highly effective delipidation reagents and water-soluble high-RI reagents (T.C. Murakami and K. Tainaka, unpublished data). Through a further combinatorial analysis, we identified the optimized cocktail of 10 w%/10 w% N-butyldiethanolamine/Triton X-100 (termed CUBIC-L) for delipidation. CUBIC-L enabled the complete delipidation of isolated paraformaldehyde (PFA)-fixed organs within 2 to 5 days, depending on the organ without pre-treatment with CUBIC-perfusion and quenching of proteins ( Figure 1A , left). We found that CUBIC-L could also permeabilize skin-detached body samples of adult mice using the CUBIC-perfusion protocol and subsequent delipidation for 7 days (Figure 1A , right; Supplemental Experimental Procedures).
As for the RI-matching step, there is an ongoing controversy about the most appropriate RI for permeabilized tissues (Tainaka et al., 2016). The RI for each intact biological tissue may depend on the contents and densities of lipids, proteins, and other constituents (Johnsen and Widder, 1999; Tuchin, 2015) . Since hydrophilic RI media with an RI over 1.52 were likely to precipitate at room temperature, we evaluated RI-matching cocktails composed of antipyrine and nicotinamide with RIs ranging from 1.44 to 1.52 for clearing permeabilized major organs, considering practical use. After a 2-day treatment, all major organs appeared to be most efficiently transparentized by the RI-matching cocktail with an RI of 1.52 ( Figures 1B and S1A) , termed CUBIC-R, which is composed of 45 w%/30 w% antipyrine/nicotinamide. Indeed, the transmittance of the chemically treated organs increased as the RI value increased (Figures 1C and S1B). We noted that all organs treated with CUBIC-L and CUBIC-R showed significantly high transmittance in the 450 to 750 nm range, probably due to the high decoloring ability of Nbutyldiethanolamine in CUBIC-L ( Figure S1C ). These results prompted us to render the whole-body clearing of adult mice using CUBIC-R (RI = 1.52) as a final RI-matching step. The transmission images of adult mice demonstrated that the new protocol markedly transparentized adult mice to visualize caudal vertebrae in ventral to dorsal (V-D) images ( Figure 1D ).
The New CUBIC Protocol Enables the Whole-Body and Whole-Organ Imaging of Adult Mice by 3D Nuclear Counterstaining and Immunohistochemistry Simultaneous visualization of cancer cells, overall organ structures, and related molecular markers would facilitate our understanding of the underlying molecular mechanisms of cancer metastasis. For the comprehensive analysis of cancer metastasis, we initially carried out nuclear counterstaining with RedDot2 or propidium iodide (PI) to acquire whole-body and whole-organ structural images using LSFM according to our previous staining protocols ( Figure 1E ) (Susaki et al., 2014; Tatsuki et al., 2016). The resulting 3D-reconstituted image of each organ enabled the visualization of anatomical structural images even in deeper regions ( Figure S1D ). The new CUBIC protocol allowed the whole-body imaging of adult mice, clearly visualizing the internal structures of cardiovascular and abdominal organs (Figures 1F and S1E) .
Next, we investigated whether the new CUBIC protocol is compatible with 3D immunohistochemistry. The brains of adult mice were co-stained with RedDot2 and anti-a-smooth muscle (D) Bright-field images of whole body of C57BL/6N mouse (6 weeks old, male) treated with CUBIC-R. After delipidation and decolorization, adult mouse bodies were treated with PBS buffer (upper) or CUBIC-R (lower). (E) Whole-body and whole-organ staining protocols. The whole-body staining protocol with PI (left) and the whole-organ staining protocol with RedDot2 or fluorescently labeled primary antibody (right) are shown. (F) The 3D-reconstituted (3D) body images of PI-stained adult C57BL/6N mouse (10 weeks old, male). Whole-body imaging (WBI), thoracic organ imaging, and abdominal organ imaging are shown. (G) The 3D-immunostained organ images. The brain from C57BL/6N mouse (15 weeks old, male) was stained with RedDot2 and fluorescein isothiocyanate (FITC)-conjugated anti-a-SMA antibody. 3D (upper) and x-y plane (XY) (lower) images are shown. The white inset was magnified next to the XY image. See also Figure S1 . actin (a-SMA) antibody according to the staining protocol (Figures 1E and 1G ). Spatial distributions of smooth muscle cells and lymphatic endothelial cells were simultaneously visualized in the lung by co-staining of a-SMA and vascular endothelial growth factor receptor 3 (VEGFR3) ( Figure S1F ). Hence, our CUBIC protocol was also applicable to 3D multiple immunohistochemical labeling. These results indicate that the new CUBIC protocol is a powerful tool for comprehensive pathological analysis.
CUBIC-Cancer Analysis Enables the Whole-Body Imaging of Cancer Metastasis at Single-Cell Resolution
To bridge the resolution gap between in vivo bioluminescence imaging and 2D histology with our scalable CUBIC-based cancer (CUBIC-cancer) analysis, we established cancer cells stably expressing firefly luciferase and fluorescence proteins, and we used them in mouse models ( Figure 2A ). First, we employed an experimental liver metastasis model by splenic injection of human pancreatic cancer cells (Panc-1). Nine weeks after injection, bioluminescence signals were detected in the abdomens of the mice ( Figure 2B , left panel). We applied the CUBIC-cancer analysis and PI-staining protocol to this mouse model, and then we acquired whole-body images with LSFM ( Figure 2A ). As a result, fluorescence signals were successfully visualized in several organs, suggesting that the CUBIC-cancer analysis is applicable to the fluorescent proteins ( Figure 2B , middle panels). In addition, magnified 3D images of these organs were obtained with CLSM in the CUBIC-cancer analysis.
We noted that the resolution of these 3D images was high enough to discriminate individual cancer cells and comparable to that of 2D hematoxylin and eosin (HE) slice images, which were obtained after CUBIC-cancer analysis ( Figure 2B , right panels). As another pathway of cancer metastasis, peritoneal dissemination model mice were generated by the intraperitoneal injection of human pancreatic cancer cells (SUIT-2). Twenty-two days after injection, mCherry signals from SUIT-2 cells were observed in the liver and small intestine by CUBIC-cancer analysis ( Figure 2C ), roughly corresponding to those of bioluminescence signals from in vivo bioluminescence imaging ( Figure S2A , left panel). Combined with counterstained confocal images, we succeeded in the direct quantification of the cell numbers of cancer colonies ( Figures 2C and 2D) . The CUBIC-cancer analysis also recapitulated cancer dissemination in other mice with SUIT-2 cells ( Figures S2B and S2C) , indicating the wide applicability of the CUBIC-cancer analysis protocol.
To prepare a syngeneic tumor model, we orthotopically injected murine renal cancer cells (Renca) into wild-type BALB/c mice. Although the formation of a primary renal tumor was visualized 2 weeks after injection, it was difficult to detect cancer metastasis to other organs by in vivo bioluminescence imaging ( Figure S2A, right panel) . In contrast, CUBIC-cancer analysis revealed that numerous metastatic colonies had widely spread to the lung, liver, pancreas, and mesenteric lymph nodes ( Figures  2E and S2D ). Using CUBIC-cancer analysis combined with LSFM and CLSM, we also succeeded in the direct quantification of the cell numbers of these dispersed metastatic colonies (Figures 2F and S2E ). Taken together, CUBIC-cancer analysis makes it possible to not only detect the dispersion of metastatic cancer cells throughout the entire body with high sensitivity but also determine the spatial distribution of individual cancer cells at single-cell resolution. In addition, CUBIC-cancer analysis is compatible with in vivo bioluminescence imaging and 2D histology.
Whole-Organ CUBIC-Cancer Analysis Provides a Systematic, Robust, Widely Applicable, and Immunolabeling-Compatible Analytical Platform for Cancer Metastasis After the comprehensive detection of cancer metastasis throughout the body, the whole-organ CUBIC-cancer analysis would globally delineate the metastatic landscape of each cancer metastasis model. To this end, whole-organ clearing and staining were conducted according to Figure 3A . Initially, we quantified the growth of primary tumors in orthotopic models with SUIT-2 cells and OS-RC-2 cells ( Figure S3A ). CUBIC-cancer analysis also permitted us to visualize metastatic colonies in whole organs, including the lung, liver, and intestine ( Figure 3B ). The colony number and volume of the metastasis in each organ were calculated ( Figure S3B ). We also exemplified CUBIC-cancer analysis with a Panc-1 cell liver metastasis model ( Figure S3C ). This highly reproducible analysis would overcome enduring issues in our understanding of in vivo metastatic progression in various cancers. Thus, CUBIC-cancer analysis enabled the complete quantification of metastatic colonies in an individual tumor-bearing mouse.
To verify CUBIC-cancer analysis as a general purpose platform, several lung metastasis models derived from various types of cancer cells were examined ( Figure 3C ). The detected redcolor signals were shown to have originated from mCherry, using immunohistochemical staining with anti-mCherry antibody (Figures 3D and S3D ). In the experimental metastasis models, all mouse cancer cells, i.e., 4T1, B16F10, and Renca cells, tended to grow to large colonies, while the morphologies of these colonies were all different. In case of experimental metastasis See also Figure S2 and Table S1. with human cancer cells, MDA-MB-231 cells also formed large colonies throughout the lungs compared to A549 cells. In contrast, in spontaneous lung metastasis with Caki-1 cells, metastatic colonies were observed throughout the lungs, but their volumes were small. Overall, we succeeded in applying CUBIC-cancer analysis to 13 different mouse models with nine cancer cell lines (Table S1 ).
These results demonstrate that whole-organ CUBIC-cancer analysis is a systematic, robust, widely applicable, and immunolabeling-compatible analytical platform for cancer metastasis. . Nevertheless, quantitative and statistical analyses of the spatial distribution of all metastatic colonies throughout the brain are still challenging. Thus, we investigated whether our CUBIC-cancer analysis can be used to classify the potentially different types of brain metastasis by quantitatively and statistically analyzing metastatic colonies in the entire organ ( Figure 4A ). The brain metastasis model of MDA-231-D cells was compared with another model using OS-RC-2 cells. Although there appeared to be no distinct difference in metastatic features between these models by in vivo bioluminescence imaging ( Figure S4A ), CUBIC-cancer analysis clearly showed that metastatic colonies in these models exhibited different histological patterns ( Figure 4B ).
Many colonies of MDA-231-D cells were localized with a-SMA-positive vascular smooth muscle cells. On the other hand, most colonies of OS-RC-2 cells were distant from a-SMA-positive vascular smooth muscle cells ( Figure 4B ). In addition, these metastatic morphological features were also identified by the histological analysis based on HE staining with or without CUBIC-cancer analysis ( Figure S4B ). To quantify the morphological features, we used the index ''volume per surface area,'' which was positively correlated with the roundness of the colony, and we found a significant difference between the two metastatic models ( Figure 4C ). Furthermore, the colonies of MDA-231-D cells tended to be smaller and closer to the blood vessels than those of OS-RC-2 cells ( Figure S4C ). These results suggest that the colony formation of OS-RC-2 cells in the brain may be dependent on cancer cell-mediated neovascularization (angiogenic growth), whereas MDA-231-D cells may be able to migrate toward pre-existing vasculatures and hijack them during the process of metastasis (co-optive growth).
For elucidating the mechanism of cancer metastasis, it is important to determine whether brain metastatic foci are generated by a single cell. To test this, equal numbers of mCherry-or GFP-expressing OS-RC-2 cells were mixed and used for intracardiac injection into the same mouse. CUBIC-cancer analysis revealed that most mCherry-positive cells in the brain were separate from the colonies of GFP-positive cells ( Figure 4D ), thus revealing the metastatic properties of individual cancer cells.
CUBIC-Cancer Analysis Is Applicable to Statistical Spatiotemporal Analysis during the Initial Steps of Metastatic Progression
The statistical spatiotemporal analysis of cancer metastasis in an entire organ has the potential to be a powerful tool for cancer research. To visualize time-dependent cancer metastasis, an experimental lung metastasis model with MDA-231-D cells was used in combination with CUBIC-cancer analysis. We then carried out whole-lung imaging of metastatic foci or colonies ( Figure 5A ). To ensure the non-biased exhaustive detection of size-variable metastatic foci, the average volume of nuclei was adopted as the threshold for focus detection ( Figure S5A ). Immunodeficient BALB/c-nu/nu mice and immunocompetent BALB/c mice were intravenously injected with MDA-231-D cells, and metastatic foci were detected by CUBIC-cancer analysis 1 hr after injection ( Figures 5B and 5C ). In total, three to four mice at each time point were analyzed ( Figures S5B and S5C) .
In BALB/c-nu/nu mice, numerous metastatic foci spread throughout the lung were drastically eliminated within 1 day after injection ( Figure 5D ). Although the number of foci continued to decrease after day 1, the average volume of the foci markedly increased from day 3, suggesting metastatic colonization. On the other hand, in BALB/c mice, metastatic foci were thoroughly excluded without any colonization ( Figures 5E and S5C ). Confocal images were used to quantify the emerged metastatic colonies on day 14 in BALB/c-nu/nu mice and the accumulated cell aggregations in BALB/c mice on day 3 ( Figures 5F and 5G ).
Since the mCherry signals were often surrounded by those of the cell aggregations, the aggregations likely reflected the immune response of the host ( Figure 5H ). Overall, CUBIC-cancer analysis enabled not only a statistical time course analysis of cancer metastasis but also direct observations of the stochastic immune-mediated elimination of metastatic foci. (C) Quantification of the morphological features in the two metastatic models. Magnified 3D and XY images of typical metastatic foci are shown. Surface analysis was applied to the 3D images in (B). As a characteristic indicator of different metastatic patterns, the volume of the foci divided by its surface area was calculated. Data represent mean ± SEM (***p < 0.001).
CUBIC-Cancer Analysis
(D) Lineage analysis using renal cancer cell lines expressing GFP or mCherry. The 3D images of the brains stained with RedDot2 (left), the frequency of the metastatic colonies consisting of a single color (middle), and the minimal distance between metastatic colonies expressing GFP or mCherry (right) are shown. Data represent mean ± SD. See also Figure S4 . 
(legend continued on next page)
To investigate the EMT roles in cancer cell arrest in microvessels of distant organs and extravasation, BALB/c-nu/nu mice were intravenously injected with A549 cells pre-treated with or without TGF-b ( Figure 6A ). Metastatic foci of A549 cells were clearly detected throughout the lung, and the colonization of the metastatic foci gradually progressed over 14 days after the early intensive elimination ( Figure 6B ). Confocal images allowed the visualization of metastatic foci around alveoli 1 hr after injection, and they showed the appearance of spheres regardless of TGF-b stimulation 14 days after injection. Interestingly, statistical analysis revealed that TGF-b stimulation significantly increased the number of metastatic foci from 1 to 14 days ( Figure 6C ).
In addition, the histological investigation after CUBIC-cancer analysis revealed that there was no clear difference between unstimulated and TGF-b-pre-stimulated cancer cells in the expression of E-cadherin in metastatic colonies 14 days after injection ( Figure 6D ). CUBIC-cancer analysis may thus be of value in elucidating unresolved issues regarding the in vivo role of the EMT in tumor metastasis.
CUBIC-Cancer Analysis Enables the Pharmacotherapeutic Profiling of Anti-tumor Drugs against Cancer Metastasis
Finally, we attempted to establish a therapeutic evaluation system for metastatic whole-lung cancers by statistically profiling metastatic cells. To assess chemotherapeutic responses in a syngeneic mouse tumor model, wild-type BALB/c mice were injected with 4T1 cells intravenously and treated with the antitumor drugs doxorubicin (Dox), 5-FU, and cyclophosphamide (CPA) ( Figure 7A ). Eight days after 4T1 injection, the proliferation of metastatic colonies tended to be suppressed in the drugtreated groups (Figures 7B and 7C ). In particular, CPA significantly reduced both the total volume and number of colonies. The daily administration of 5-FU resulted in the drastic reduction of metastatic colonies ( Figure 7D ). Importantly, many metastatic foci were still detected in the lungs of 5-FU-treated mice, indicating the high sensitivity of CUBIC-cancer analysis. Some foci were composed of just a single cancer cell, which might be dormant or resistant to anti-tumor drugs ( Figures 7D and 7E) . Taken together, CUBIC-cancer analysis can be used to evaluate the in vivo effects of anti-tumor drugs at the single-cell level.
DISCUSSION

RI-Optimized CUBIC Protocol Enables the Scalable Whole-Body Cell Profiling of Various Cancer Models
The RI values of tissue and cell structures are highly diverse, ranging from 1.34 to 1.59, because the RI for each intact biological tissue depends on the contents and densities of lipids, proteins, and other constituents (Tuchin, 2015) . Therefore, optimal RI values were likely to be dependent on each organ. The results of the transmittance evaluation of major organs mounted on various RI media indicated that the transparency of the organs tended to increase as the RI values increased ( Figures  1C and S1B) . Interestingly, this tendency was observed regardless of the organ, suggesting that these organs mostly contain the constituents with relatively similar RI values. We noted that the RI value-dependent increase in the transparency of most of the organs did not reach a plateau, even at an RI of 1.52. It would be very difficult to prepare hydrophilic RI-matching media with higher RI values (RI > 1.52) using current chemical candidates, because of their water solubility or low RI value per unit mass. Future development of such RI-matching media (RI > 1.52) may be favorable to make these organs transparent more efficiently. Another technical challenge is to develop whole-body-clearing protocols compatible with bone tissue clearing. Mild, effective, and highly permeable decalcification methods compatible with our CUBIC protocol would facilitate our understanding of the mechanisms of cancer metastases, including bone metastasis. We noted that perfusion-assisted agent release in situ (PARS) and ultimate 3D imaging of solvent-cleared organs (uDISCO) protocols might be also applicable to whole-body profiling of cancer metastasis with a To obtain an overview of cancer metastasis, it would be important to create a global analytical pipeline visualizing the overall dynamics of metastatic progression, spatiotemporal distribution of metastatic colonies at single-cell resolution, and their surrounding microenvironments. In this study, we attempted to bridge the resolution gap between in vivo bioluminescence imaging and 2D histology by our scalable CUBIC-cancer analysis, using cancer cell lines stably expressing luciferase and fluorescent proteins.
We determined whether fluorescent signals in whole-body and whole-organ images actually originated from cancer cells or indirectly originated from some other cells, such as phagocytes that digested labeled cancer cells. To compare the in vivo bioluminescence imaging and CUBIC-cancer analysis, we performed in vivo bioluminescence imaging before tissue clearing. 
(legend on next page)
Bioluminescence images from luciferase activity roughly corresponded to the fluorescent signals ( Figures 2B, 3B, S2C , and S3C), despite apparent differences in multiple organ metastases by Renca cells (Figures 2E and S2A ) and brain metastasis by MDA-231-D cells (Figures 4B and S4A ). In the former case, bioluminescence signals in metastatic organs may not have been detected with this dynamic range because the signals were too intense at the primary lesion. In the latter case, bioluminescence signals may have been shielded by the skull, and they seemed to leak out to the eyes and neck ( Figure S4A ). In addition, because we could perform HE staining of CUBIC-treated organs, we compared the CUBIC-cancer analysis results with the data obtained by the conventional histological method. We found that the basic tissue pathology was well preserved in HE staining, and we could detect the tumors in the CUBIC-treated samples ( Figures 2B and 6B) . However, the histology of the metastatic tumors of OS-RC-2 cells, which are clear cell renal carcinoma and contain high amounts of glycogen, was distinct between the intact samples and samples after CUBIC-cancer analysis, possibly because of the delipidation process ( Figure S4B ). These observations indicated that certain CUBIC-treated samples can be used for immunohistochemical analysis, although the cell membrane in the samples may be damaged due to delipidation. Together, CUBIC-cancer analysis could successfully bridge the resolution gap between conventional in vivo bioluminescence imaging and 2D histology. . In this study, we investigated the relevance of the EMT in lung metastasis by statistical and temporal analysis of metastatic colonies in an experimental extravasation model ( Figure 6 ). The nature of the in vivo dynamics of metastatic extravasation is an ongoing controversy. While the metastatic extravasation was postulated to proceed over 1-2 days (Tsai and Yang, 2013), another group demonstrated using an in vitro extravasation assay that cancer cells could extravasate from microvessels within 3 hr (Spiegel et al., 2016). Our results showed that the number of foci at 1 hr after injection was not significantly different, suggesting that the EMT appears to be not involved in the arrest of cells in microvessels. To our surprise, the number of metastatic foci markedly increased on day 1 after the injection of cells pre-treated with TGF-b1, and this number was approximately sustained up to day 14 ( Figure 6C ). These findings suggest that the fate of cancer cells in metastatic sites is determined in the very early phase (within a day) after arriving at distant organs, and that the EMT might be associated with the survival of cancer cells at metastatic sites. The EMT is thought to confer stem cell-like features that allow cells to disseminate and gain resistance to apoptosis or anti-tumor therapies (Polyak and Weinberg, 2009). Hence, the significant promotion of metastasis by EMT induction may reflect the transformation of differentiated cells into a stem cell-like phenotype, including the induction of extracellular matrix production and gaining of the resistance to apoptosis.
EMT Significantly Promotes the Extravasation or Survival of Cancer Cells In Vivo
Plasticity between the epithelial and mesenchymal phenotypes also plays a pivotal role in the process of metastasis (Ye and Weinberg, 2015). In clinical studies, intravasated cancer cells circulating in the blood have been shown to exhibit the mesenchymal phenotype, while colonized cancer cells in organs were found to exhibit the epithelial phenotype (Kallergi et al., 2011; Kowalski et al., 2003). Because of the relatively shortterm stimulation of A549 cells by TGF-b1 in the present study, we assumed that the plasticity of the EMT was maintained in this experiment. In fact, our results suggested that A549 cells that colonized the lung were restored to the epithelial phenotype with the restoration of E-cadherin expression. Taken together, our CUBIC-cancer analysis clarified the in vivo dynamics of the plasticity between the epithelial and mesenchymal phenotypes during the progression of cancer metastasis through the statistical analysis of metastatic foci at the whole-organ level.
CUBIC-Cancer Analysis Provides an In Vivo Therapeutic Evaluation System to Aid in the Treatment of Metastatic Tumors
To quantitatively evaluate the therapeutic effects of anti-tumor drugs, it is necessary to establish an ultra-sensitive detection system that can determine whether metastatic colonies are completely eliminated or whether single cancer cells resistant to anti-tumor drugs still remain. This distinction is particularly important because the emergence of chemoresistant cancer cells eventually leads to the proliferation of cancer cells and the development of incurable tumors. It is difficult to detect metastasized cells at single-cell resolution by in vivo bioluminescence imaging, and visualizing whole-organ images by 2D histology is labor intensive. Notably, our CUBIC-cancer analysis of the entire lung successfully detected tiny foci consisting of even a single cancer cell ( Figures 7D and 7E) . Therefore, our CUBIC-cancer analysis may provide critical information for the development of a curative treatment for metastasis.
Furthermore, we wish to emphasize another important advantage of CUBIC-cancer analysis: it allows a seamless connection between in vivo live imaging and 2D histology, complementing the shortcomings of each modality. The global analytical pipeline consisting of these methods is quite robust and reliable, because the experimental data could be thoroughly verified by the three modalities. An in vivo therapeutic evaluation system is urgently needed not only for malignant neoplastic diseases but also for autoimmune diseases, which remain a challenge clinically, and emerging induced pluripotent stem cell (iPSC)-based regenerative therapies. This analytical pipeline would have great potential for becoming a de facto standard for an in vivo therapeutic evaluation system for complex systemic diseases.
EXPERIMENTAL PROCEDURES
Details are also supplied in the Supplemental Experimental Procedures.
Preparation of Clearing Solutions
Clearing solutions were composed of four chemicals, which were selected from chemical screening (T.C. Murakami and K. Tainaka, unpublished data). CUBIC-L for decolorization and delipidation was prepared as a mixture of 10 w% polyethylene glycol mono-p-isooctylphenyl ether/Triton X-100 (12967-45, Nacalai Tesque) and 10 w% N-buthyldiethanolamine (B0725, Tokyo Chemical Industry). CUBIC-R for RI matching was prepared as a mixture of 45 w% 2,3-dimethyl-1-phenyl-5-pyrazolone/antipyrine (D1876, Tokyo Chemical Industry) and 30 w% nicotinamide (N0078, Tokyo Chemical Industry) (Table S2 ). See also the Supplemental Experimental Procedures.
Microscopy
Whole-body and whole-organ images were acquired with a custom-build LSFM (developed by Olympus). High-resolution images for cell profiling were acquired with CLSM (FLUOVIEW FV1200, Olympus). The RI-matched sample was immersed in a mixture of silicon oil HIVAC-F4 (Shin-Etsu Chemical) and mineral oil (RI = 1.467, M8410, Sigma-Aldrich) during image acquisition. See also the Supplemental Experimental Procedures. (A) Bright-field images of whole organs (pancreas and spleen) from C57BL/6N mouse (13 weeks old, male) 3 after RI adjustment (RI=1.44, 1.45, 1.46, 1.47, 1.48, 1.49, 1.50, 1.51, and 1.52 1 Table S2 . List of the name of CUBIC solutions 1
Experimental and Spontaneous Mouse Metastatic Tumor Models
We developed four clearing solutions as below. 
Preparation of Clearing Solutions 3
Compared with previous CUBIC solutions, the viscosity of CUBIC-L and CUBIC-R is relatively low. Although 4 the water content of CUBIC-R is low to achieve high RI, CUBIC-R is unlikely to precipitate and easy to handle. and used in Figure 1G , S1D, S1F, 3C (MDA-MB-231), 4 (MDA-231-D). 7
8
The CUBIC Protocol for Whole-body and Whole-organ Clearing 9
For the preparation of whole-organ clearing samples, adult mice (C57BL/6N) were sacrificed by an overdose of 10 pentobarbital (> 100 mg/kg, Kyoritsu Seiyaku, Tokyo, Japan) and then perfused with 20 ml of PBS (pH 7.4) and 11 30 ml of 4% (w/v) PFA (02890-45, Nacalai Tesque) in PBS via left ventricle of the heart. The excised organs 12
were post-fixed in 4% (w/v) PFA at 4°C for 24 hours. The specimens were washed with PBS for more than 2 13 hours three times to remove PFA just before clearing. The fixed organs were immersed in 50% (v/v) CUBIC-L 14
(1:1 mixture of water and CUBIC-L) for more than 6 hours and further immersed in CUBIC-L with gentle 15 shaking at 37°C for 2-5 days, depending on the organs (typically 3 days for the heart, lung, intestine, pancreas, 16 and spleen, and 5 days for the brain, liver, and kidney). CUBIC-L should be daily refreshed during the procedure. 17
After decolorization and delipidation, the organs were washed with PBS at room temperature for more than 2 18 hours three times. The organs were further immersed in 50% (v/v) CUBIC-R (1:1 mixture of water and 19 CUBIC-R) for more than 6 hours, and then in CUBIC-R at room temperature with gentle shaking for at least 1 20
day. 21
For the preparation of whole-body clearing samples, anesthetized mice were perfused with 30 ml of 22 PBS, 150 ml of 4% (w/v) PFA in PBS, 20 ml of PBS, and 100 ml of 50% (v/v) CUBIC-L in this order via left 23 ventricle of the heart. The mice were immersed in 200 ml of 50% (v/v) CUBIC-L at 37°C for more than 6 hours, 24
and further immersed in CUBIC-L at 37°C with gentle shaking for at least 5 days. After decolorization and 25 delipidation, mice were washed with PBS at room temperature for 1 day. Mice were further immersed in 50% 26 CUBIC-R for 1 day, and then in CUBIC-R at room temperature with gentle shaking for at least 1 day. Although 27 bone tissues, gastrointestinal tissues, brown adipose tissues, and eyeball were still difficult to be transparentizedin this protocol, it was sufficiently clear enough to execute whole-body and whole-organ scanning of cancer 1
